Sana Biotechnology, Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€10.82M - Gross profit
-€2.45M - SG&A expenses
€45.61M - R&D expenses
€128.88M - EBITDA
-€208.53M - D&A
€13.95M - EBIT
-€221.56M - Interest expenses
€0.00 - EBT
-€216.37M - Tax expenses
€0.00 - Net income
-€216.37M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€29.71M - Changes in working capital
-€8.84M - Operating cash flow
-€155.07M - Capex
€3.91M - Other investing cash flow
€217.07K - Net investing cash flow
€97.08M - Total cash dividends paid
€0.00 - Issuance of common stock
€478.76K - Debt repayment
-€146.72K - Other financing cash flow
€3.38M - Net financing cash flow
€3.66M - Foreign exchange effects
€0.00 - Net change in cash
-€54.33M - Cash at end of period
€64.75M - Free cash flow
-€151.17M
Balance sheet
- Cash and cash equivalents
€61.15M - Cash and short-term investments
€62.35M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€8.43M - Total current assets
€70.79M - Property, plant & equipment
€65.30M - Goodwill
€120.66M - Intangible assets
€50.79M - Long-term investments
€0.00 - Other non-current assets
€2.76M - Total non-current assets
€239.50M - Total assets
€310.29M - Accounts payable
€1.95M - Short-term debt
€11.87M - Other current liabilities
€14.88M - Total current liabilities
€28.69M - Long-term debt
€122.97M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€114.96M - Total non-current liabilities
€176.44M - Total liabilities
€205.14M - Common stock
€19.73K - Retained earnings
-€1.50B - Other equity
€0.00 - Total equity
€105.15M - Total liabilities and shareholders' equity
€310.29M
Company information
- Market capitalization
€540.61M - Employees
194 - Enterprise Value
€604.18M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-205.8% Much worse than peer group: -47.9% - ROA
-
-69.7% Much worse than peer group: -44.9% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-29.4% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€1.12M